These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32449212)

  • 1. Engineered PD-L1-Expressing Platelets Reverse New-Onset Type 1 Diabetes.
    Zhang X; Kang Y; Wang J; Yan J; Chen Q; Cheng H; Huang P; Gu Z
    Adv Mater; 2020 Jul; 32(26):e1907692. PubMed ID: 32449212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes.
    Yang Z; Zhang Z; Li L; Jing Z; Ma Y; Lan T; Li Y; Lin Z; Fang W; Zhang J; Zhang J; Liang X; Wu B; Zheng Y; Zhang X
    Diabetes; 2024 Aug; 73(8):1325-1335. PubMed ID: 38771941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel mimovirus encoding ChgA
    Sun H; Han X; Yan X; Xu J; Huang Q; Meng F; Zhang H; Li S
    Cell Immunol; 2017 Oct; 320():56-61. PubMed ID: 28916112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes.
    Ben Nasr M; Tezza S; D'Addio F; Mameli C; Usuelli V; Maestroni A; Corradi D; Belletti S; Albarello L; Becchi G; Fadini GP; Schuetz C; Markmann J; Wasserfall C; Zon L; Zuccotti GV; Fiorina P
    Sci Transl Med; 2017 Nov; 9(416):. PubMed ID: 29141886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
    Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
    Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.
    Wang CJ; Chou FC; Chu CH; Wu JC; Lin SH; Chang DM; Sytwu HK
    Diabetes; 2008 Jul; 57(7):1861-9. PubMed ID: 18420489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade.
    Kawada-Horitani E; Kita S; Okita T; Nakamura Y; Nishida H; Honma Y; Fukuda S; Tsugawa-Shimizu Y; Kozawa J; Sakaue T; Kawachi Y; Fujishima Y; Nishizawa H; Azuma M; Maeda N; Shimomura I
    Diabetologia; 2022 Jul; 65(7):1185-1197. PubMed ID: 35511238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protecting Stem Cell Derived Pancreatic Beta-Like Cells From Diabetogenic T Cell Recognition.
    Castro-Gutierrez R; Alkanani A; Mathews CE; Michels A; Russ HA
    Front Endocrinol (Lausanne); 2021; 12():707881. PubMed ID: 34305820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue expression of PD-L1 mediates peripheral T cell tolerance.
    Keir ME; Liang SC; Guleria I; Latchman YE; Qipo A; Albacker LA; Koulmanda M; Freeman GJ; Sayegh MH; Sharpe AH
    J Exp Med; 2006 Apr; 203(4):883-95. PubMed ID: 16606670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the PD-1/PD-L1 Dyad in the Maintenance of Pancreatic Immune Tolerance for Prevention of Type 1 Diabetes.
    Falcone M; Fousteri G
    Front Endocrinol (Lausanne); 2020; 11():569. PubMed ID: 32973682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
    Rajasalu T; Brosi H; Schuster C; Spyrantis A; Boehm BO; Chen L; Reimann J; Schirmbeck R
    Diabetes; 2010 Aug; 59(8):1966-73. PubMed ID: 20484136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma drives programmed death-ligand 1 expression on islet β cells to limit T cell function during autoimmune diabetes.
    Osum KC; Burrack AL; Martinov T; Sahli NL; Mitchell JS; Tucker CG; Pauken KE; Papas K; Appakalai B; Spanier JA; Fife BT
    Sci Rep; 2018 May; 8(1):8295. PubMed ID: 29844327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice.
    Filippi CM; Estes EA; Oldham JE; von Herrath MG
    J Clin Invest; 2009 Jun; 119(6):1515-23. PubMed ID: 19478458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A missing PD-L1/PD-1 coinhibition regulates diabetes induction by preproinsulin-specific CD8 T-cells in an epitope-specific manner.
    Schuster C; Brosi H; Stifter K; Boehm BO; Schirmbeck R
    PLoS One; 2013; 8(8):e71746. PubMed ID: 23977133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes.
    Pauken KE; Jenkins MK; Azuma M; Fife BT
    Diabetes; 2013 Aug; 62(8):2859-69. PubMed ID: 23545706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.
    Martin-Orozco N; Wang YH; Yagita H; Dong C
    J Immunol; 2006 Dec; 177(12):8291-5. PubMed ID: 17142723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice.
    Li R; Lee J; Kim MS; Liu V; Moulik M; Li H; Yi Q; Xie A; Chen W; Yang L; Li Y; Tsai TH; Oka K; Chan L; Yechoor V
    Diabetes; 2015 Feb; 64(2):529-40. PubMed ID: 25332429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IDO-Expressing Fibroblasts Protect Islet Beta Cells From Immunological Attack and Reverse Hyperglycemia in Non-Obese Diabetic Mice.
    Zhang Y; Jalili RB; Kilani RT; Elizei SS; Farrokhi A; Khosravi-Maharlooei M; Warnock GL; Ao Z; Marzban L; Ghahary A
    J Cell Physiol; 2016 Sep; 231(9):1964-73. PubMed ID: 26743772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.